Inventor · disambiguated record
Xing Dai
Also filed as: DAI XING · DAI XING-YI
48 granted patents·21 pending applications·108 citations·filing 1986–2025
97Inventor score
Files withINVENTISBIO CO LTD30MERCK SHARP & DOHME15INVENTISBIO LLC5MCCOMAS CASEY C3BEIJING SENSETIME TECH DEVELOPMENT CO LTD2
Top patents by PatentIndex Score
69 records- 0197US11091481B2Heterocyclic compounds, preparation and methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Granted Aug 17, 2021·5 cites·10 claims
- 0296US11241418B2Salts of selective estrogen receptor degradersINVENTISBIO SHANGHAI LTD·Filed 2020·Granted Feb 8, 2022·5 cites·11 claims
- 0396US11205284B2Vehicle-mounted camera pose estimation method, apparatus, and system, and electronic deviceBEIJING SENSETIME TECH DEVELOPMENT CO LTD·Filed 2020·Granted Dec 21, 2021·7 cites·18 claims
- 0495US9718818B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Aug 1, 2017·25 cites·9 claims
- 0591US9364482B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Granted Jun 14, 2016·8 cites·15 claims
- 0690US9243002B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CMERCK SHARP & DOHME·Filed 2014·Granted Jan 26, 2016·8 cites·17 claims
- 0789US10980807B2Inhibitor of indoleamine-2,3-dioxygenase (IDO)INVENTISBIO LLC·Filed 2017·Granted Apr 20, 2021·5 cites·11 claims
- 0889US10647724B2Selective estrogen receptor degraders and uses thereofINVENTISBIO INC·Filed 2017·Granted May 12, 2020·5 cites·28 claims
- 0988US9265773B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 23, 2016·8 cites·15 claims
- 1083US12246020B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Granted Mar 11, 2025·0 cites·20 claims
- 1183US10689401B2C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Jun 23, 2020·2 cites·7 claims
- 1282US9242998B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CHE SHUWEN·Filed 2014·Granted Jan 26, 2016·8 cites·17 claims
- 1380US12187736B2Selective estrogen receptor degraders and uses thereofINVENTISBIO LLC·Filed 2023·Granted Jan 7, 2025·0 cites·18 claims
- 1480US9573939B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 21, 2017·6 cites·6 claims
- 1579US11014936B2Selective estrogen receptor degraders and uses thereofINVENTISBIO INC·Filed 2019·Granted May 25, 2021·1 cites·18 claims
- 1679US2024165088A1Novel salts of selective estrogen receptor degradersINVENTISBIO CO LTD·Filed 2024·Application pending·0 cites
- 1777US11903931B2Salts of selective estrogen receptor degradersINVENTISBIO CO LTD·Filed 2022·Granted Feb 20, 2024·0 cites·12 claims
- 1877US2025313545A1Heteroaryl compounds, solid forms, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2025·Application pending·0 cites
- 1976US11969425B2Inhibitor of indoleamine-2,3-dioxygenase (IDO)INVENTISBIO LLC·Filed 2023·Granted Apr 30, 2024·0 cites·24 claims
- 2075US11685720B2Salt forms of URAT-1 inhibitorsINVENTISBIO CO LTD·Filed 2022·Granted Jun 27, 2023·0 cites·19 claims
- 2175US8361959B2Spiro-imidazolone derivatives as glucagon receptor antagonistsMERCK SHARP & DOHME·Filed 2009·Granted Jan 29, 2013·2 cites·18 claims
- 2274US11865115B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2022·Granted Jan 9, 2024·0 cites·3 claims
- 2373US9809568B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·1 cites·10 claims
- 2472US2024025876A1Heteroaryl compounds, solid forms, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Application pending·0 cites
- 2571US12391677B2Thyroid hormone receptor agonistsINVENTISBIO CO LTD·Filed 2019·Granted Aug 19, 2025·0 cites·10 claims
- 2671US9688654B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Jun 27, 2017·1 cites·10 claims
- 2771US9440952B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Sep 13, 2016·1 cites·19 claims
- 2870US12173010B2Heterocyclic compounds, preparation methods therefor, and methods of uses thereofINVENTISBIO CO LTD·Filed 2023·Granted Dec 24, 2024·0 cites·19 claims
- 2970US11339127B2Salt forms of URAT-1 inhibitorsINVENTISBIO SHANGHAI LTD·Filed 2019·Granted May 24, 2022·0 cites·19 claims
- 3070US11241437B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Granted Feb 8, 2022·0 cites·23 claims
- 3169US12492184B2Heteroaryl compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Granted Dec 9, 2025·0 cites·2 claims
- 3269US12227491B2EGFR inhibitorsINVENTISBIO CO LTD·Filed 2023·Granted Feb 18, 2025·0 cites·20 claims
- 3369US10047098B2C5-C6-oxacyclic fused iminopyrimidinone compounds as bace inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2015·Granted Aug 14, 2018·1 cites·12 claims
- 3469US2021253592A1Selective estrogen receptor degraders and uses thereofINVENTISBIO LLC·Filed 2021·Application pending·0 cites
- 3569US2025340542A1Thyroid hormone receptor agonistsINVENTISBIO CO LTD·Filed 2025·Application pending·0 cites
- 3667US11639344B2EGFR inhibitorsINVENTISBIO CO LTD·Filed 2019·Granted May 2, 2023·0 cites·9 claims
- 3767US9549917B2Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Jan 24, 2017·1 cites·14 claims
- 3865US2022054486A1Inhibitor of indoleamine-2,3-dioxygenase (ido)INVENTISBIO LLC·Filed 2021·Application pending·0 cites
- 3961US12110289B2Heterocyclic compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2021·Granted Oct 8, 2024·0 cites·17 claims
- 4061US11041820B1Magnetic holder for immunoelectron microscopy gridsINST MICROBIOLOGY CAS·Filed 2021·Granted Jun 22, 2021·0 cites·13 claims
- 4161US11008338B2C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their useMERCK SHARP & DOHME·Filed 2020·Granted May 18, 2021·0 cites·10 claims
- 4260US2025223301A1Kinase inhibitors, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Application pending·0 cites
- 4360US2025263394A1Compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2023·Application pending·0 cites
- 4459US2024189313A1Solid dispersionsINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 4558US11691981B2Heterocyclic compounds, preparation methods therefor, and methods of uses thereofINVENTISBIO CO LTD·Filed 2020·Granted Jul 4, 2023·0 cites·21 claims
- 4657US2024343727A1Pyridazinone or pyridinone compounds, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 4756US2025195475A1Cdk2 inhibitor and preparation method and use thereofINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 4855US12509448B2Salts of indoleamine 2,3-dioxygenase inhibitorsINVENTISBIO CO LTD·Filed 2020·Granted Dec 30, 2025·0 cites·12 claims
- 4955US2025215014A1Kinase inhibitors, preparation methods and uses thereofINVENTISBIO CO LTD·Filed 2022·Application pending·0 cites
- 5055US2023263782A1Oral formulations and uses thereofINVENTISBIO CO LTD·Filed 2021·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Xing Dai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →